These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29206600)

  • 1. The changes before 'the change'.
    Bachmann AG
    Postgrad Med; 1994 Apr; 95(4):113-124. PubMed ID: 29206600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changes before 'the change'. Strategies for the transition to the menopause.
    Bachmann GA
    Postgrad Med; 1994 Mar; 95(4):113-5, 119-21, 124. PubMed ID: 8121848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contraceptives: knowledge and compliance].
    Koch T; Marslew U; Nielsen MR
    Ugeskr Laeger; 1993 Nov; 155(44):3546-50. PubMed ID: 8236575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contraceptive needs of midlife women.
    Jarrett ME; Lethbridge DJ
    Nurse Pract; 1990 Dec; 15(12):34-9. PubMed ID: 2284060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What contraceptive measures for women in their 40s and 50s?
    Friedman S
    JAMA; 1974 Nov; 230(5):759. PubMed ID: 12306451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a low-dose progestagen as a contraceptive.
    Iizuka R; Hayashi M; Kamouchi Y; Yamanaka K
    Nihon Funin Gakkai Zasshi; 1971; 16(1):68-82. PubMed ID: 12158578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
    Victor A; Lithell H; Selinus I; Vessby B
    Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual change during the menopause transition: do women find it problematic?
    Mackey S
    Maturitas; 2009 Oct; 64(2):114-8. PubMed ID: 19720481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genitourinary symptoms in the menopausal transition.
    Van Voorhis BJ
    Am J Med; 2005 Dec; 118 Suppl 12B():47-53. PubMed ID: 16414326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
    Sherman BM; West JH; Korenman SG
    J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition.
    Graziottin A; Leiblum SR
    J Sex Med; 2005 Sep; 2 Suppl 3():133-45. PubMed ID: 16422790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause.
    Depypere HT; Hillard T; Erkkola R; Lukkari-Lax E; Kunz M; Rautiainen P; Schram JH
    Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):176-80. PubMed ID: 20888118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing menstrual disturbances.
    Barnett B
    Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health.
    Pacello PC; Yela DA; Rabelo S; Giraldo PC; Benetti-Pinto CL
    Climacteric; 2014 Aug; 17(4):342-7. PubMed ID: 24188246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception during perimenopausal years is important issue for patients, clinicians.
    Colls JP
    Contracept Technol Update; 1984 Dec; 5(12):158-60. PubMed ID: 12339714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility awareness affects method use.
    Barnett B
    Netw Res Triangle Park N C; 1996; 17(1):9. PubMed ID: 12320448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
    Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
    Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.